Skip to main content
. 2001 Sep;75(17):7791–7802. doi: 10.1128/JVI.75.17.7791-7802.2001

TABLE 1.

Oligonucleotides used for linker-insertion mutagenesis, primer-directed mutagenesis, and RT-PCR

Oligonucleotide Sequencea (5′→3′) Nucleotide positions (BVDV CP7)
BEMLU acgcgt
BALU gatcgacgcgtc
NIPLU cacgcgtgtgca
SALU tcgagacgcgtc
BESLU gtgacgacgcgt
BESLU-R gtcacacgcgtc
HILU agctacgcgtgg
HILU-R agctccacgcgt
BVD CS 11 tttcggcagaagatcttcctaccacttg 7224–7197
L2336R cacccactgctcgctcctttagttc 7413–7389
L2683R+ gggaagatacgtaaccggtctgggaattatg 8427–8457
L2683R− cataattcccagaccggttacgtatcttccc 8457–8427
5ABLSDPs cctataccatgaaggatcctagttggtttcttc 9916–9948
5ABLSDPas gaagaaaccaactaggatccttcatggtatagg 9948–9916
B38 cagtccagacaattggc 8266–8282
B42 gttgggatcactttagtt 9270–9287
B49R agaacaaagggcctttcat 9469–9451
B53R cctgcttccgtcattatg 10372–10355
a

Restriction sites introduced by the mutation are underlined (MluI in BEMLU, BALU, NIPLU, SALU, BESLU, BESLU-R, HILU, and HILU-R; BglII in BVD CS 11; SnaBI in L2683R+ and L2683R−; BamHI in 5ABLSDPs and 5ABLSDPas). Mutated nucleotides are indicated by italics.